- Home
- VYGR vs NNY Comparison
VYGR vs NNY Comparison
Compare VYGR & NNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- NNY
- Stock Information
- Founded
- VYGR 2013
- NNY 1987
- Country
- VYGR United States
- NNY United States
- Employees
- VYGR N/A
- NNY N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- NNY Investment Managers
- Sector
- VYGR Health Care
- NNY Finance
- Exchange
- VYGR Nasdaq
- NNY Nasdaq
- Market Cap
- VYGR 165.5M
- NNY 155.1M
- IPO Year
- VYGR 2015
- NNY N/A
- Fundamental
- Price
- VYGR $2.74
- NNY $8.18
- Analyst Decision
- VYGR Strong Buy
- NNY
- Analyst Count
- VYGR 8
- NNY 0
- Target Price
- VYGR $14.33
- NNY N/A
- AVG Volume (30 Days)
- VYGR 377.3K
- NNY 50.9K
- Earning Date
- VYGR 05-06-2025
- NNY 01-01-0001
- Dividend Yield
- VYGR N/A
- NNY 4.04%
- EPS Growth
- VYGR N/A
- NNY N/A
- EPS
- VYGR N/A
- NNY N/A
- Revenue
- VYGR $66,958,000.00
- NNY N/A
- Revenue This Year
- VYGR N/A
- NNY N/A
- Revenue Next Year
- VYGR $45.34
- NNY N/A
- P/E Ratio
- VYGR N/A
- NNY N/A
- Revenue Growth
- VYGR N/A
- NNY N/A
- 52 Week Low
- VYGR $2.65
- NNY $7.58
- 52 Week High
- VYGR $9.55
- NNY $8.87
- Technical
- Relative Strength Index (RSI)
- VYGR 33.88
- NNY 48.19
- Support Level
- VYGR $2.71
- NNY $8.09
- Resistance Level
- VYGR $2.99
- NNY $8.79
- Average True Range (ATR)
- VYGR 0.18
- NNY 0.23
- MACD
- VYGR -0.05
- NNY -0.01
- Stochastic Oscillator
- VYGR 10.86
- NNY 22.47
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About NNY Nuveen New York Municipal Value Fund
Nuveen New York Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from both regular federal and New York state income taxes, by investing in a portfolio of municipal obligations issued by state and local government authorities within the state of New York or certain U.S. territories.